Nissay Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,920
| Closed | -$412K | – | 772 |
|
|
2023
Q2 | $412K | Sell |
9,920
-182
| -2% | -$7.55K | ﹤0.01% | 713 |
|
|
2023
Q1 | $608K | Sell |
10,102
-404
| -4% | -$24.3K | 0.01% | 674 |
|
|
2022
Q4 | $771K | Sell |
10,506
-239
| -2% | -$17.5K | 0.01% | 646 |
|
|
2022
Q3 | $816K | Buy |
10,745
+436
| +4% | +$33.1K | 0.01% | 617 |
|
|
2022
Q2 | $716K | Buy |
10,309
+148
| +1% | +$10.3K | 0.01% | 635 |
|
|
2022
Q1 | $842K | Buy |
10,161
+208
| +2% | +$17.2K | 0.01% | 650 |
|
|
2021
Q4 | $747K | Buy |
9,953
+201
| +2% | +$15.1K | 0.01% | 683 |
|
|
2021
Q3 | $1.13M | Buy |
9,752
+461
| +5% | +$53.6K | 0.01% | 599 |
|
|
2021
Q2 | $2.06M | Buy |
9,291
+304
| +3% | +$67.4K | 0.02% | 440 |
|
|
2021
Q1 | $1.19M | Sell |
8,987
-161
| -2% | -$21.3K | 0.01% | 570 |
|
|
2020
Q4 | $1.58M | Buy |
+9,148
| New | +$1.58M | 0.02% | 467 |
|